BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shao JW, Ge TT, Chen SZ, Wang G, Yang Q, Huang CH, Xu LC, Chen Z. Role of bile acids in liver diseases mediated by the gut microbiome. World J Gastroenterol 2021; 27(22): 3010-3021 [PMID: 34168404 DOI: 10.3748/wjg.v27.i22.3010]
URL: https://www.wjgnet.com/1007-9327/full/v27/i22/3010.htm
Number Citing Articles
1
Yi Zhen Han, Hui Juan Zheng, Bo Xuan Du, Yi Zhang, Xing Yu Zhu, Jing Li, Yao Xian Wang, Wei Jing Liu, Balamurugan Ramatchandirin. Role of Gut Microbiota, Immune Imbalance, and Allostatic Load in the Occurrence and Development of Diabetic Kidney DiseaseJournal of Diabetes Research 2023; 2023: 1 doi: 10.1155/2023/8871677
2
Dmitry Victorovich Garbuzenko. Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosisWorld Journal of Hepatology 2023; 15(4): 525-537 doi: 10.4254/wjh.v15.i4.525
3
Feng Zhu, Shudan Zheng, Mei Zhao, Fan Shi, Lihong Zheng, Haiqiang Wang. The regulatory role of bile acid microbiota in the progression of liver cirrhosisFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1214685
4
Smaragda Ntona, Apostolis Papaefthymiou, Jannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis, Marina Boziki, Stergios A. Polyzos, Maria Tzitiridou, Dimitrios Chatzopoulos, Tharshika Thavayogarajah, Ioanna Gkolia, Georgios Ntonas, Elisabeth Vardaka, Michael Doulberis. Impact of nonalcoholic fatty liver disease-related metabolic state on depressionNeurochemistry International 2023; 163: 105484 doi: 10.1016/j.neuint.2023.105484
5
Nicolas Richard, Guillaume Savoye, Mathilde Leboutte, Asma Amamou, Subrata Ghosh, Rachel Marion-Letellier. Crohn’s disease: Why the ileum?World Journal of Gastroenterology 2023; 29(21): 3222-3240 doi: 10.3748/wjg.v29.i21.3222
6
Fuchang Deng, Guangqiu Qin, Yuanyuan Chen, Xu Zhang, Mu Zhu, Min Hou, Qiao Yao, Wen Gu, Chao Wang, Hui Yang, Xudong Jia, Chongming Wu, Hui Peng, Huamao Du, Song Tang. Multi-omics reveals 2-bromo-4,6-dinitroaniline (BDNA)-induced hepatotoxicity and the role of the gut-liver axis in ratsJournal of Hazardous Materials 2023; 457: 131760 doi: 10.1016/j.jhazmat.2023.131760
7
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Viral Liver Disease and Intestinal Gut–Liver AxisGastrointestinal Disorders 2024; 6(1): 64 doi: 10.3390/gidisord6010005
8
Hui Zhang, Xiao Cui, Wei Liu, Zheng Xiang, Ji-Feng Ye. Regulation of intestinal microflora and metabolites of Penthorum chinense Pursh on alcoholic liver diseaseFrontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1331956
9
Nasreen Nazar, A. S. Athira, Ranjit Kumar Nadella, Satyen Kumar Panda, Kaushik Banerjee, Niladri Sekhar Chatterjee. Untargeted metabolomics offers insights into the risks of chronic exposure to mixtures of polycyclic aromatic hydrocarbons at environmentally relevant low concentrationsEnvironmental Geochemistry and Health 2025; 47(6) doi: 10.1007/s10653-025-02547-0
10
Anuradha Tyagi, Vinay Kumar. The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic healthWorld Journal of Microbiology and Biotechnology 2025; 41(7) doi: 10.1007/s11274-025-04395-7
11
Shuqin Lin, Yunjuan Xiao, Siyu Li, Liyan Tang, Haitao Shi, Meiling Hong, Li Ding. Thiacloprid exposure disrupts the gut-liver axis and induces liver dysfunction in the Reeves' turtles (Mauremys reevesii)Ecotoxicology and Environmental Safety 2025; 289: 117710 doi: 10.1016/j.ecoenv.2025.117710
12
Kimia Mohammadhasani, Mohammad Vahedi Fard, Ali Mottaghi Moghaddam Shahri, Zahra Khorasanchi. Polyphenols improve non‐alcoholic fatty liver disease via gut microbiota: A comprehensive reviewFood Science & Nutrition 2024; 12(8): 5341 doi: 10.1002/fsn3.4178
13
Vinay Jahagirdar, Mohammed Faisal Habeeb, Anand V. Kulkarni. Antimicrobial Resistance in CirrhosisCurrent Hepatology Reports 2024; 23(3): 423 doi: 10.1007/s11901-024-00654-7
14
Yiming Ni, Mengna Lu, Yuan Xu, Qixue Wang, Xinyi Gu, Ying Li, Tongxi Zhuang, Chenyi Xia, Ting Zhang, Xiao-jun Gou, Mingmei Zhou. The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver DiseaseFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.908011
15
Ming-Yu Jin, Xiao-Yong Wu, Mei-Ying Li, Hao Deng, Ri-Ming Huang, Yuan-Ming Sun, Cheol-Heui Yun, Zhen-Lin Xu. Noni (Morinda citrifolia L.) Fruit Polysaccharide Attenuated Inflammatory Bowel Disease Mice: Association of STAT3/NLRP3 Signaling PathwaysACS Food Science & Technology 2023; 3(11): 1965 doi: 10.1021/acsfoodscitech.3c00351
16
Russell R. Fling, Timothy R. Zacharewski. Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Dose-Dependently Shifts the Gut Microbiome Consistent with the Progression of Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2021; 22(22): 12431 doi: 10.3390/ijms222212431
17
Chang Sun, Xing Zhou, Ting Guo, Jia Meng. The immune role of the intestinal microbiome in knee osteoarthritis: a review of the possible mechanisms and therapiesFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1168818
18
Yi-Zhen Han, Bo-Xuan Du, Xing-Yu Zhu, Yang-Zhi-Yuan Wang, Hui-Juan Zheng, Wei-Jing Liu. Lipid metabolism disorder in diabetic kidney diseaseFrontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1336402
19
Yu Zhang, Hongbing Xie, Lirong Wang, Jianhe Hu, Lei Wang, Shouping Zhang. Effect of Weaning at 21 Days of Age on the Content of Bile Acids in Chyme of CecumAnimals 2022; 12(16): 2138 doi: 10.3390/ani12162138
20
Huiji Pan, Meiling Zhou, Zhao Ju, Jinhua Luo, Jing Jin, Liangfang Shen, Pingkun Zhou, Ruixue Huang. Potential role of gut microbiota-LCA-INSR axis in high fat-diet-induced non-alcoholic fatty liver dysfunction: From perspective of radiation variationCurrent Research in Food Science 2022; 5: 1685 doi: 10.1016/j.crfs.2022.09.022
21
Yanfang Zheng, Jiaying Chen, Ying Zhang, Huaying Guan, Shan Deng, Dennis Chang, Yitao Wang, JinJian Lu, Xian Zhou, Qin Xie, Jianyuan Song, Mingqing Huang. Gut Microbiota and Bile Acid Metabolism in the Mechanism of Ginsenoside Re Against Nonalcoholic Fatty Liver DiseasePhytotherapy Research 2025; 39(5): 2339 doi: 10.1002/ptr.8474
22
Liming Liu, Liquan Deng, Wei Wei, Chunhua Li, Yuting Lu, Jieying Bai, Letian Li, Heping Zhang, Ningyi Jin, Chang Li, Cuiqing Zhao. Lactiplantibacillus plantarum LPJZ-658 Improves Non-Alcoholic Steatohepatitis by Modulating Bile Acid Metabolism and Gut Microbiota in MiceInternational Journal of Molecular Sciences 2023; 24(18): 13997 doi: 10.3390/ijms241813997
23
Tao Wang, Xu-Jiong Li, Ling-Hao Qin, Xue Liang, Huan-Huan Xue, Jing Guo, Shi-Fei Li, Li-Wei Zhang. Better detoxifying effect of ripe forsythiae fructus over green forsythiae fructus and the potential mechanisms involving bile acids metabolism and gut microbiotaFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.987695
24
Dorna Hashemi, Mohammad Vahedi Fard, Kimia Mohammadhasani, Mehdi Barati, Elyas Nattagh‐Eshtivani. Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative ReviewFood Science & Nutrition 2025; 13(3) doi: 10.1002/fsn3.70092
25
Hui Yan, Guige Xu, Lei Bei, Shijin Jiang, Ruihua Zhang. Duck hepatitis A virus type 1 infection induces hepatic metabolite and gut microbiota changes in ducklingsPoultry Science 2024; 103(2): 103265 doi: 10.1016/j.psj.2023.103265
26
Morgane M. Thibaut, Justine Gillard, Adeline Dolly, Martin Roumain, Isabelle A. Leclercq, Nathalie M. Delzenne, Giulio G. Muccioli, Laure B. Bindels. Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing MiceCancers 2021; 13(24): 6389 doi: 10.3390/cancers13246389
27
Yulin Guo, Feng Cao, Fei Li. Impacts of pancreatic exocrine insufficiency on gut microbiotaJournal of Zhejiang University-SCIENCE B 2024; 25(4): 271 doi: 10.1631/jzus.B2300070
28
Yang Bao, Xiao Han, Da Liu, Zhaolin Tan, Yongzhi Deng. Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine – a case study of diabetes and nonalcoholic fatty liver diseaseFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1072376
29
Miguel Suárez, Raquel Martínez, Ana María Torres, Antonio Ramón, Pilar Blasco, Jorge Mateo. Personalized Risk Assessment of Hepatic Fibrosis after Cholecystectomy in Metabolic-Associated Steatotic Liver Disease: A Machine Learning ApproachJournal of Clinical Medicine 2023; 12(20): 6489 doi: 10.3390/jcm12206489
30
Nahum Mendez-Sanchez, Carlos Esteban Coronel-Castillo, Jacqueline Cordova-Gallardo, Xingshun Qi. Antibiotics in Chronic Liver Disease and Their Effects on Gut MicrobiotaAntibiotics 2023; 12(10): 1475 doi: 10.3390/antibiotics12101475
31
María Luisa Ojeda, Fátima Nogales, José A. Carrasco López, María del Carmen Gallego-López, Olimpia Carreras, Ana Alcudia, Eloísa Pajuelo. Microbiota-Liver-Bile Salts Axis, a Novel Mechanism Involved in the Contrasting Effects of Sodium Selenite and Selenium-Nanoparticle Supplementation on Adipose Tissue Development in Adolescent RatsAntioxidants 2023; 12(5): 1123 doi: 10.3390/antiox12051123
32
Chang Sun, Chenguang Qiu, Yanyan Zhang, Man Yan, Jiajun Tan, Jiayuan He, Dakai Yang, Dongxu Wang, Liang Wu. Lactiplantibacillus plantarum NKK20 Alleviates High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Regulating Bile Acid AnabolismMolecules 2023; 28(10): 4042 doi: 10.3390/molecules28104042
33
Koichi Sudo, Amber Delmas-Eliason, Shannon Soucy, Kaitlyn E. Barrack, Jiabao Liu, Akshaya Balasubramanian, Chengyi Jenny Shu, Michael J. James, Courtney L. Hegner, Henry D. Dionne, Alex Rodriguez-Palacios, Henry M. Krause, George A. O’Toole, Saul J. Karpen, Paul A. Dawson, Daniel Schultz, Mark S. Sundrud. Quantifying Forms and Functions of Enterohepatic Bile Acid Pools in MiceCellular and Molecular Gastroenterology and Hepatology 2024; 18(6): 101392 doi: 10.1016/j.jcmgh.2024.101392
34
D.V. Garbuzenko. Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potentialDokazatel'naya gastroenterologiya 2022; 11(4): 65 doi: 10.17116/dokgastro20221104165
35
Haoyu Bian, Liping Zhang, Yupu Yao, Fuqi Lv, Jiaoyang Wei. How traditional Chinese medicine can prevent recurrence of common bile duct stones after endoscopic retrograde cholangiopancreatography?Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1363071